Work

Safety, Pharmacokinetics and Pharmacodynamics of the GLP ‐1/ GIP / GCG Receptor Agonist UBT251 Injection: A Randomized, Placebo‐Controlled Phase 1a/1b Study

Year: 2026

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Diabetes Obesity and Metabolism

DOI: 10.1111/dom.71327

Authors: Guo‐ping Yang, Ya‐xin Liu, Jin‐lian Xie, Shan Zeng, Jing Xiong, Wei Ling, Hai‐yan Zhang, Tao Su, Yu‐xiu Xu, Liang Huang, Thomas Holst‐Hansen, Sofie Bay, Hui‐ru Yan, Jie Huang, Ping Jin

Institutions: Central South University, Third Xiangya Hospital, Xiangya Hospital Central South University, Novo Nordisk (Denmark)

Language: English

Topic: Pharmacology and Obesity Treatment

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Transnationale Universiteit Limburg

OpenAlex ID: W7212034093

FWCI: 3.9

Cites: 12

Cited by: 1

Related to: